Fora Capital, LLC Castle Biosciences Inc Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $25,014 - $32,281	-416 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $47,766 - $73,248	-954 Reduced 69.64%	416 $31 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $467,235 - $771,826	-7,930 Reduced 85.27%	1,370 $94 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $385,162 - $645,323	8,834 Added 1895.71%	9,300 $624,000
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $17,927 - $24,245	466 New	466 $24 Million

201

24.4M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $712M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.